Key result
Phlorizin attenuates isoprenaline-induced myocardial fibrosis and pyroptosis via HK1/NLRP3 pathway inhibition in mice.
Why the study?
The specific role of phlorizin on myocardial fibrosis and its related pharmacological mechanisms remained unknown.
Does phlorizin ameliorate isoprenaline-induced myocardial fibrosis by inhibiting pyroptosis through restraining HK1-mediated NLRP3 inflammasome activation in mice?
Does phlorizin ameliorate isoprenaline-induced myocardial fibrosis by inhibiting pyroptosis through restraining HK1-mediated NLRP3 inflammasome activation in mice?
In a preclinical mouse model, phlorizin attenuated isoprenaline-induced myocardial fibrosis by reducing oxidative stress, mitochondrial damage, apoptosis, and HK1/NLRP3-mediated pyroptosis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for phlorizin in myocardial fibrosis; leaves open translation to human disease pending clinical trials.
The specific role of phlorizin (PHL), which has antioxidant, anti-inflammatory, hypoglycemic, antiarrhythmic and antiaging effects, on myocardial fibrosis (MF) and the related pharmacological mechanisms remain unknown. The objective of this study was to determine the protective actions of PHL on isoprenaline (ISO)-induced MF and its molecular mechanisms in mice. PHL was administered at 100 and 200 mg/kg for 15 consecutive days with a subcutaneous injection of ISO (10 mg/kg). MF was induced by ISO and alleviated by treatment with PHL, as shown by reduced fibrin accumulation in the myocardial interstitium and decreased levels of myocardial enzymes, such as creatinine kinase-MB, lactate dehydrogenase, and aspartate transaminase. In addition, PHL significantly decreased the expression of the fibrosis-related factors alpha smooth muscle actin, collagen I, and collagen III induced by ISO. The generation of intracellular reactive oxygen species induced by ISO was attenuated after PHL treatment. The malondialdehyde level was reduced, whereas the levels of superoxide dismutase, catalase, and glutathione were elevated with PHL administration. Moreover, compared to ISO, the level of Bcl-2 was increased and the level of Bax protein was decreased in the PHL groups. PHL relieved elevated TNF-α, IL-1β, and IL-18 levels as well as cardiac mitochondrial damage resulting from ISO. Further studies showed that PHL downregulated the high expression of hexokinase 1 (HK1), NLRP3, ASC, Caspase-1, and GSDMD-N caused by ISO. In conclusion, our findings suggest that PHL protects against ISO-induced MF due to its antioxidant, anti-apoptotic, and anti-inflammatory activities and via inhibition of pyroptosis mediated by the HK1/NLRP3 signaling pathway in vivo .
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) studied Isoprenaline (ISO)-induced myocardial fibrosis (n=50). Phlorizin vs. 0.5% carboxymethylcellulose sodium (intragastric) + isoprenaline 10 mg/kg/day (subcutaneous) was evaluated on Myocardial injury area and fibrosis markers (alpha-SMA, Collagen I, Collagen III) (p=<0.01). Phlorizin alleviated isoprenaline-induced myocardial fibrosis, oxidative stress, apoptosis, and HK1/NLRP3-mediated pyroptosis in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: